WELL Health Technologies

Persistent M&A Risks Will Challenge Digital Health Resilience

AnalystLowTarget

Not Invested

Community Contributor

Published

11 Jul 25

AnalystLowTarget's Fair Value

CA$5.60

7.4% undervalued

03 Sep

CA$5.19

14.6%

-5.1%

14.6%

-5.1%

You can edit this narrative until Jul 11 10:21 PM. Then, changes will post as Updates.

Author's Valuation

CA$5.67.4% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

CA$5.6

7.4% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

14.26%

Healthcare Services revenue growth rate

0.23%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

5.97%

Calculation

CA$154.20m

Earnings '28

11.59x

PE Ratio '28

CA$1.79b

Market Cap '28

CA$1.79b

Market Cap '28

268.35m

No. shares '28

CA$6.66

Share Price '28

CA$6.66 Share Price '28

Discounted to 2025 @ 5.97% p.a.

CA$5.60

Fair Value '25